Clinical trialNCT02584140CompletedPhase 4Interventional

Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women

SponsorUniversity of California, Los AngelesEnrollment136HIV Prevention

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to test a program that uses drug level monitoring, text messaging ("iTAB") and personalized counseling with HIV prevention services, including PrEP (medicine that can help prevent HIV infection when taken daily).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Raphael Landovitz, MD
University of California, Los Angeles
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
Sheldon Morris, MD
UCSD
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Apla Health & Wellness' Gleicher / Chen Health Center
Los Angeles, California, United States
Los Angeles Biomedical Research Institute at Harbor-Ucla
Los Angeles, California, United States
T.H.E. at Ruth Temple
Los Angeles, California, United States
Usc 5p21 Rand Schrader Clinic
Los Angeles, California, United States
Ucsd Antiviral Research Center
San Diego, California, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Daily Oral PrEP

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 May 2016
Primary completion: 15 May 2019
Completion: 14 Jun 2019
Last update posted: 8 Jul 2021
Registered enrollment: 136
Registry id: NCT02584140

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.